Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by Peytonon Nov 03, 2018 12:15pm
73 Views
Post# 28919113

RE:Profitability

RE:Profitability We are not close to turning a profit yet. But it will come. 

WeedTheNorth wrote: The last quarters, the company has been expanding to 10x their ability to supply product without the ability to sell 10x of their product.  Now we don’t really have a sales restriction.  Between Canada medical and Rec, German medical, and all the other countries in various stages, every grown gram should be able to be sold within the same quarter, give or take.

now comes the value.  We are growing, packaging and shipping to medical patients door for $2.50/g.  The question is, what is the revenue collected for the 68,000 kg MOU recreation sales most likely at a wholesale price.  We sell into Germany for $13+/g.  We make the total margin on medical sales in Canada.

with the ability to match 10x cost with 10x sales, we will be pumping profits, certainly by the next quarter, if not thinly by this coming one on the 14th.

GL all, 4 month wait at the most to see the difference between Canopy and those other suppliers.


Bullboard Posts